In tumor cells, UBR5 fine-tunes MYC protein levels, balancing cell growth and survival, thus contributing to therapeutic resistance by protecting breast tumors from MYC-mediated apoptosis-priming [63]. The gene discussed is UBR5; the disease is neoplasm.